Otis Johnson PHD, MPA

Dr. Otis Johnson is a distinguished figure in clinical research and a passionate health equity advocate. His career began with a transformative 13-year tenure in scientific and operational roles at Merck. He later enhanced clinical development strategies at Syneos Health and ICON and led the growth of Clario's Trial Oversight analytics business into a major success. Dr. Johnson is recognized as a PharmaVoice 100 most inspiring industry leader and has received numerous awards for his work in diversity, equity, and inclusion, including the 2024 Healthcare Businesswomen’s Association’s (HBA) Honorable Mentor Award. Currently, he is the Co-founder of Trial Equity, aiming to improve patient representation in clinical trials to ensure that medicines are safe and effective for all people. In his last role, he was Chief Diversity, Inclusion & Sustainability Officer at Clario.